Management of pregnancy-related disorders to prevent future risk of coronary artery disease
### Learning objectives Ischaemic heart disease results in 7.5 million deaths worldwide and remains the leading cause of death in women.1 Additionally, pregnancy-related maternal morbidity in the world has increased nearly 200% between 1993 and 2014 in the USA.2 Adverse pregnancy outcomes (APOs), which include hypertensive disorders of pregnancy (HDPs), such as pre-eclampsia, gestational diabetes mellitus (GDM), preterm delivery and small-for-gestational-age infants, are common and occur in 17–20% of all pregnancies in the USA.3 Mounting evidence over the past several decades has demonstrated that a history of APOs robustly predicts later-life risk of cardiovascular disease (CVD), including coronary artery disease (CAD) and heart failure, in affected individuals.4 5 APOs and CVD share similar risk factors, including obesity, hypertension, metabolic syndrome, race and suboptimal social determinants of health (SDOHs).6 The American Heart Association’s (AHA) Life’s Essential 8 framework r
